184 - How AI Created a Billion-Dollar Company With Just 2 People

Vic and Marcus recap the Jumpstart Health Summit, including a workshop where non-technical founders built full AI-driven products and an agentic investment bank in under 48 hours, followed by key discussions from the summit on healthcare transformation, AI infrastructure, venture capital evolution, and leadership changes at Jumpstart Health. They break down major economic signals including declining job openings, stock market performance, and rising risks in private credit markets, then analyze healthcare policy shifts targeting hospital pricing practices and UnitedHealthcare’s push into AI-driven member tools. The episode also covers major pharma momentum led by Eli Lilly across acquisitions, GLP-1 advancements, and AI-powered drug discovery, alongside emerging trends in crypto-backed mortgages, agentic commerce, and Coinbase’s expanding role in financial infrastructure. They close with a deep dive into AI disruption, highlighting a two-person billion-dollar company, open-source model acceleration, security risks, and breakthroughs that could reshape hardware demand and the future of work.

Links

Story 1 Jobs and Equity market

11:37 - U.S. Job Openings and Hiring Fell in February WSJ

18:10 - Here’s What Worked During a Rough Quarter for Markets WSJ

Story 2 Private credit watch

19:17 - What Banks Stand to Lose From the Private-Credit Mess WSJ

Story 3 VC rundown

23:14 - WHOOP Secures $575M, Reaches $10B Valuation MedCity

Story 4  DOJ v NY Pres

25:21 - Justice Department Files Antitrust Lawsuit Against NewYork-Presbyterian WSJ

Story 6 UHG launches AI Companion

30:12 - UnitedHealthcare launches Avery, a generative AI companion for members Fierce Healthcare

Story 7 1st Reimbursement for Robot Companion

32:22 - Intuition Robotics secures Medicaid coverage for social AI robot ElliQ in Washington State Fierce Healthcare

Story 8 Eli Lilly moves

37:21 - Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion WSJ

37:55 - Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill MedCity

38:52 - Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market CNBC

Story 9 Web3 rundown

39:54 - Fannie Mae to Accept Crypto-Backed Mortgages for the First Time WSJ

41:54 - Coinbase’s AI payments system joins Linux Foundation, gathers support from Google, Stripe, AWS and others Coindesk

45:57 - Coinbase clears key regulatory hurdle in bid to bolster its stablecoin business CNBC 

Story 10 1st $B - 2 person AI startup is healthcare

47:24 - How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company NYT

Story 11 Antropic

50:27 - Anthropic Races to Contain Leak of Code Behind Claude AI Agent WSJ

51:19 - Claw Code Launches Open-Source AI Coding Agent Framework With 72,000 GitHub Stars in First Days 24-7

Story 12 Google

54:00 - Google announces Gemma 4 open AI models, switches to Apache 2.0 license ArsTechnica

56:30 - Google now lets you direct avatars through prompts in its Vids app TechCrunch

57:00 - Google’s TurboQuant Breakthrough Just Rewrote the AI Playbook Yahoo